STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCYT
  4. [Form 4] VERACYTE, INC. Insider Trading Activity

Veracyte (VCYT) director Eliav Barr receives 5,272 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Barr Eliav reported acquisition or exercise transactions in this Form 4 filing.

VERACYTE, INC. director Eliav Barr received a grant of 5,272 shares of common stock in the form of restricted stock units. These RSUs were awarded on June 11, 2026 and increase his direct holdings to 56,461 shares. The units vest in full on the first anniversary of the grant date or immediately before the company’s next annual meeting of stockholders, whichever comes first. They also vest in full if there is a change in control of the company.

Positive

  • None.

Negative

  • None.
Insider Barr Eliav
Role null
Type Security Shares Price Value
Grant/Award Common Stock 5,272 $0.00 --
Holdings After Transaction: Common Stock — 56,461 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 5,272 shares Restricted stock units awarded on June 11, 2026
Holdings after transaction 56,461 shares Total direct common stock holdings after grant
Grant price per share $0.00 per share Compensation-related RSU award, not market purchase
restricted stock units financial
"Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
annual meeting of stockholders financial
"or immediately prior to the Company's next annual meeting of stockholders, if earlier"
change in control financial
"the restricted stock units vest in full in the event of a change in control of the Issuer"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Barr Eliav
(Last)(First)(Middle)
6000 SHORELINE COURT, SUITE 300
(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/11/2026A(1)5,272A$056,461D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer.
Remarks:
/s/ Jonathan Wygant as attorney-in-fact06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Veracyte (VCYT) report for Eliav Barr?

Veracyte reported that director Eliav Barr received a grant of 5,272 restricted stock units of common stock. The award was made on June 11, 2026 and is a compensation-related grant, not an open-market stock purchase or sale.

How many Veracyte (VCYT) shares does Eliav Barr hold after this Form 4?

After the restricted stock unit grant of 5,272 shares, Eliav Barr now holds 56,461 shares of Veracyte common stock directly. This figure reflects his total direct ownership as reported following the June 11, 2026 award transaction.

When do Eliav Barr’s Veracyte (VCYT) restricted stock units vest?

The 5,272 restricted stock units awarded to Eliav Barr vest in full on the first anniversary of the June 11, 2026 grant date, or immediately before Veracyte’s next annual meeting of stockholders, if that meeting occurs earlier than the one-year anniversary date.

What happens to Eliav Barr’s Veracyte (VCYT) RSUs if there is a change in control?

If Veracyte undergoes a change in control, the 5,272 restricted stock units granted to Eliav Barr vest in full. This means all units become fully earned and no longer subject to the time-based vesting schedule described in the award’s terms.

Did Eliav Barr buy or sell Veracyte (VCYT) shares in the market?

The Form 4 shows a grant of 5,272 restricted stock units to Eliav Barr at a price of $0.00 per share. This is a compensation-related award, not an open-market purchase or sale of Veracyte common stock by the director.